share_log

ノイルイミューン・バイオテック:NIB102及びNIB103のライセンス契約の解消に関する追加コメント

Noile-Immune Biotech: Additional comments on the cancellation of the NIB102 and NIB103 license agreements

JPX ·  Dec 15, 2023 18:45
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more